mRNA vaccines offer numerous benefits, including cost-effectiveness, significant R&D flexibility, high manufacturing efficiency, exceptional safety profiles, and broad potential in the medical field. These novel vaccines necessitate stringent quality control measures to guarantee product stability and safety.